Fullerenes
Medicine & Life Sciences
100%
neuropeptide Y5 receptor
Medicine & Life Sciences
69%
Fullerene
Chemical Compounds
47%
P62
Chemical Compounds
43%
Agent Interacting With Transmitter, Hormone or Drug Receptor
Chemical Compounds
34%
Benzbromarone
Chemical Compounds
33%
Neuropeptide Y Receptors
Medicine & Life Sciences
32%
Metabolic Activation
Chemical Compounds
30%
Acyl Coenzyme A
100%
Acyl-CoA
96%
Hepatocytes
62%
Glucuronides
61%
Liver Microsomes
57%
Katagishi, D. ,
Yasuda, D. ,
Takahashi, K. ,
Nakamura, S. ,
Mashino, T. &
Ohe, T. ,
2023 1月 15 ,
In: Bioorganic and Medicinal Chemistry Letters. 80 , 129121.
研究成果: Article › 査読
SARS coronavirus 3C-like protease
100%
Fullerenes
78%
Fullerene
44%
malonic acid
38%
SARS Virus
36%
Sumi, K. ,
Tago, K. ,
Nakazawa, Y. ,
Takahashi, K. ,
Ohe, T. ,
Mashino, T. &
Funakoshi-Tago, M. ,
2022 2月 5 ,
In: European journal of pharmacology. 916 , 174714.
研究成果: Article › 査読
Fullerenes
100%
Leukemia
50%
Reactive Oxygen Species
49%
Apoptosis
37%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
21%
Kadota, A. ,
Moriguchi, M. ,
Watanabe, T. ,
Sekine, Y. ,
Nakamura, S. ,
Yasuno, T. ,
Ohe, T. ,
Mashino, T. &
Fujimuro, M. ,
2022 3月 ,
In: Oncology reports. 47 ,
3 , 8257.
研究成果: Article › 査読
Fullerenes
100%
Primary Effusion Lymphoma
93%
Catenins
78%
Wnt Signaling Pathway
70%
Cell Survival
47%
Yasuda, D. ,
Yoshida, I. ,
Imamura, R. ,
Katagishi, D. ,
Takahashi, K. ,
Kojima, H. ,
Okabe, T. ,
Ichimura, Y. ,
Komatsu, M. ,
Mashino, T. &
Ohe, T. ,
2022 1月 ,
In: Results in Chemistry. 4 , 100609.
研究成果: Article › 査読
P62
100%
Protein
24%
Doxorubicin
15%
Antineoplastic Agent
13%
Amide
10%